Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study.

Viruses · 2023 · PMC10054373 · PMID 36992413

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

borderline non-significantp = 0.052so close (0.05 < p ≤ 0.1)

An initial approach to differences in patient outcomes showed that regarding PS, a statistically significant difference of mild versus severe cases ( p = 0.041) was observed, while the difference between mild and moderate cases was borderline non-significant ( p = 0.052).

also in 47 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.